Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase

Expression of breast cancer resistance protein/ATP-binding cassette sub-family G member 2 (BCRP/ABCG2) is the major cause of chemotherapy failure. It is important to establish and characterize the multidrug resistance cells and to investigate the mechanism of multidrug resistance. Multidrug-resistan...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta biochimica et biophysica Sinica 2010-12, Vol.42 (12), p.854-862
Hauptverfasser: Ji, Nana, Yuan, Jianhui, Liu, Jianjun, Tian, Shengli
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 862
container_issue 12
container_start_page 854
container_title Acta biochimica et biophysica Sinica
container_volume 42
creator Ji, Nana
Yuan, Jianhui
Liu, Jianjun
Tian, Shengli
description Expression of breast cancer resistance protein/ATP-binding cassette sub-family G member 2 (BCRP/ABCG2) is the major cause of chemotherapy failure. It is important to establish and characterize the multidrug resistance cells and to investigate the mechanism of multidrug resistance. Multidrug-resistant cells expressing BCRP/ABCG2 based on human breast cancer MCF-7/wt cells were developed by gradually increasing application of low concentration of mitoxantrone. Real-time quantitative PCR, western blot, and immunofluorescence assay were employed to analyze BCRP mRNA and protein expression. Drug accumulation in the cells was measured by flow cytometry and DNA methyltransferases were analyzed by western blot. The results indicated that the inhibitory ratio of cell proliferative growth exhibited an exponential relation with the concentration of mitoxantrone. The ICs0 of MCF-7/wt cells to mitoxantrone was found to be 0.42 μM. 3-(4,5-Dimethylthlthiazol-2-YI)- 2,5-Diphenyltetrazolium Bromide assay indicated that the mitoxantrone-resistant cells at different stages exhibited cross-resistance to adriamycin and taxol. BCRP/ABCG2 mRNA and protein levels in the mitoxantrone-resistant cells at different stages increased with increasing concentration of mitoxantrone. Intracellular accumulation of mitoxantrone in the cells decreased with the increase of the BCRP/ABCG2 expression levels. DNA methyltransferase 1 (DNMT1) and DNA methyltransferase 3a (DNMT3a) expressions in the cells at different stages decreased slightly, whereas DNA methyltransferase 3b (DNMT3b) expression decreases significantly. BCRP/ABCG2 overexpression and its drug-efflux function in the drug-resistant cells are the main factors to produce multidrug resistance. Our results suggest that multidrug resistance is related to overexpression of BCRP/ ABCG2 and the decrease of DNA methyltransferases, especially DNMT3b.
doi_str_mv 10.1093/abbs/gmq097
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_814462520</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>36305407</cqvip_id><oup_id>10.1093/abbs/gmq097</oup_id><sourcerecordid>814462520</sourcerecordid><originalsourceid>FETCH-LOGICAL-c388t-d78d1fd613f6d4e1713119bf1d31bb211fa34941969f3356e1d1f975dd7c950b3</originalsourceid><addsrcrecordid>eNqF0E1v1DAQBmALgegHnLijiEM5oLCeOLHXx-22FKQKEIKz5cTjbcCJs7ZTqPjzONqFK6fx4fE7mpeQF0DfApVspds2rnbDnkrxiJyCqJtSVII-zm8uqlJC3ZyQsxi_U8o4B_qUnFQAlAsuTsnvK7xH56d-3BXD7FJvwrwrA8Y-Jj2mokPnYqFHU-CvyfmwuM6HgE6n3o9Fi-kn4lhcbr98Xm0utzdV4e8xlFnnkLiQ5fPVx00xYLp7cCnoMVoMOuIz8sRqF_H5cZ6Tb--uv27fl7efbj5sN7dlx9brVBqxNmANB2a5qREEMADZWjAM2jafYjWrZQ2SS8tYwxEyl6IxRnSyoS07J68PuVPw-xljUkMfl8P0iH6Oag11zaumolm-Ocgu-BgDWjWFftDhQQFVS9lqKVsdys765TF3bgc0_-zfdjO4OAA_T_9JenXce-fH3T6XrFrd_bC9Q8U4o01NBfsDb_eVrA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>814462520</pqid></control><display><type>article</type><title>Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Ji, Nana ; Yuan, Jianhui ; Liu, Jianjun ; Tian, Shengli</creator><creatorcontrib>Ji, Nana ; Yuan, Jianhui ; Liu, Jianjun ; Tian, Shengli</creatorcontrib><description>Expression of breast cancer resistance protein/ATP-binding cassette sub-family G member 2 (BCRP/ABCG2) is the major cause of chemotherapy failure. It is important to establish and characterize the multidrug resistance cells and to investigate the mechanism of multidrug resistance. Multidrug-resistant cells expressing BCRP/ABCG2 based on human breast cancer MCF-7/wt cells were developed by gradually increasing application of low concentration of mitoxantrone. Real-time quantitative PCR, western blot, and immunofluorescence assay were employed to analyze BCRP mRNA and protein expression. Drug accumulation in the cells was measured by flow cytometry and DNA methyltransferases were analyzed by western blot. The results indicated that the inhibitory ratio of cell proliferative growth exhibited an exponential relation with the concentration of mitoxantrone. The ICs0 of MCF-7/wt cells to mitoxantrone was found to be 0.42 μM. 3-(4,5-Dimethylthlthiazol-2-YI)- 2,5-Diphenyltetrazolium Bromide assay indicated that the mitoxantrone-resistant cells at different stages exhibited cross-resistance to adriamycin and taxol. BCRP/ABCG2 mRNA and protein levels in the mitoxantrone-resistant cells at different stages increased with increasing concentration of mitoxantrone. Intracellular accumulation of mitoxantrone in the cells decreased with the increase of the BCRP/ABCG2 expression levels. DNA methyltransferase 1 (DNMT1) and DNA methyltransferase 3a (DNMT3a) expressions in the cells at different stages decreased slightly, whereas DNA methyltransferase 3b (DNMT3b) expression decreases significantly. BCRP/ABCG2 overexpression and its drug-efflux function in the drug-resistant cells are the main factors to produce multidrug resistance. Our results suggest that multidrug resistance is related to overexpression of BCRP/ ABCG2 and the decrease of DNA methyltransferases, especially DNMT3b.</description><identifier>ISSN: 1672-9145</identifier><identifier>EISSN: 1745-7270</identifier><identifier>DOI: 10.1093/abbs/gmq097</identifier><identifier>PMID: 21106767</identifier><language>eng</language><publisher>China: Oxford University Press</publisher><subject>Antineoplastic Agents - pharmacology ; ATP Binding Cassette Transporter, Sub-Family G, Member 2 ; ATP-Binding Cassette Transporters - antagonists &amp; inhibitors ; ATP-Binding Cassette Transporters - genetics ; ATP-Binding Cassette Transporters - metabolism ; Blotting, Western ; Breast Neoplasms - metabolism ; Breast Neoplasms - pathology ; Cell Proliferation - drug effects ; DNA Modification Methylases - genetics ; DNA Modification Methylases - metabolism ; DNA甲基转移酶 ; Drug Resistance, Neoplasm ; Female ; Fluorescent Antibody Technique ; Gene Expression Regulation, Neoplastic - drug effects ; Humans ; Mycotoxins - pharmacology ; Neoplasm Proteins - genetics ; Neoplasm Proteins - metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Tumor Cells, Cultured ; 人乳腺癌细胞 ; 多药耐药 ; 实时定量PCR ; 米托蒽醌 ; 蛋白表达 ; 过度表达</subject><ispartof>Acta biochimica et biophysica Sinica, 2010-12, Vol.42 (12), p.854-862</ispartof><rights>The Author 2010. Published by ABBS Editorial Office in association with Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c388t-d78d1fd613f6d4e1713119bf1d31bb211fa34941969f3356e1d1f975dd7c950b3</citedby><cites>FETCH-LOGICAL-c388t-d78d1fd613f6d4e1713119bf1d31bb211fa34941969f3356e1d1f975dd7c950b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/90160X/90160X.jpg</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21106767$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ji, Nana</creatorcontrib><creatorcontrib>Yuan, Jianhui</creatorcontrib><creatorcontrib>Liu, Jianjun</creatorcontrib><creatorcontrib>Tian, Shengli</creatorcontrib><title>Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase</title><title>Acta biochimica et biophysica Sinica</title><addtitle>Acta Biochimica et Biophysica Sinica</addtitle><description>Expression of breast cancer resistance protein/ATP-binding cassette sub-family G member 2 (BCRP/ABCG2) is the major cause of chemotherapy failure. It is important to establish and characterize the multidrug resistance cells and to investigate the mechanism of multidrug resistance. Multidrug-resistant cells expressing BCRP/ABCG2 based on human breast cancer MCF-7/wt cells were developed by gradually increasing application of low concentration of mitoxantrone. Real-time quantitative PCR, western blot, and immunofluorescence assay were employed to analyze BCRP mRNA and protein expression. Drug accumulation in the cells was measured by flow cytometry and DNA methyltransferases were analyzed by western blot. The results indicated that the inhibitory ratio of cell proliferative growth exhibited an exponential relation with the concentration of mitoxantrone. The ICs0 of MCF-7/wt cells to mitoxantrone was found to be 0.42 μM. 3-(4,5-Dimethylthlthiazol-2-YI)- 2,5-Diphenyltetrazolium Bromide assay indicated that the mitoxantrone-resistant cells at different stages exhibited cross-resistance to adriamycin and taxol. BCRP/ABCG2 mRNA and protein levels in the mitoxantrone-resistant cells at different stages increased with increasing concentration of mitoxantrone. Intracellular accumulation of mitoxantrone in the cells decreased with the increase of the BCRP/ABCG2 expression levels. DNA methyltransferase 1 (DNMT1) and DNA methyltransferase 3a (DNMT3a) expressions in the cells at different stages decreased slightly, whereas DNA methyltransferase 3b (DNMT3b) expression decreases significantly. BCRP/ABCG2 overexpression and its drug-efflux function in the drug-resistant cells are the main factors to produce multidrug resistance. Our results suggest that multidrug resistance is related to overexpression of BCRP/ ABCG2 and the decrease of DNA methyltransferases, especially DNMT3b.</description><subject>Antineoplastic Agents - pharmacology</subject><subject>ATP Binding Cassette Transporter, Sub-Family G, Member 2</subject><subject>ATP-Binding Cassette Transporters - antagonists &amp; inhibitors</subject><subject>ATP-Binding Cassette Transporters - genetics</subject><subject>ATP-Binding Cassette Transporters - metabolism</subject><subject>Blotting, Western</subject><subject>Breast Neoplasms - metabolism</subject><subject>Breast Neoplasms - pathology</subject><subject>Cell Proliferation - drug effects</subject><subject>DNA Modification Methylases - genetics</subject><subject>DNA Modification Methylases - metabolism</subject><subject>DNA甲基转移酶</subject><subject>Drug Resistance, Neoplasm</subject><subject>Female</subject><subject>Fluorescent Antibody Technique</subject><subject>Gene Expression Regulation, Neoplastic - drug effects</subject><subject>Humans</subject><subject>Mycotoxins - pharmacology</subject><subject>Neoplasm Proteins - genetics</subject><subject>Neoplasm Proteins - metabolism</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Tumor Cells, Cultured</subject><subject>人乳腺癌细胞</subject><subject>多药耐药</subject><subject>实时定量PCR</subject><subject>米托蒽醌</subject><subject>蛋白表达</subject><subject>过度表达</subject><issn>1672-9145</issn><issn>1745-7270</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0E1v1DAQBmALgegHnLijiEM5oLCeOLHXx-22FKQKEIKz5cTjbcCJs7ZTqPjzONqFK6fx4fE7mpeQF0DfApVspds2rnbDnkrxiJyCqJtSVII-zm8uqlJC3ZyQsxi_U8o4B_qUnFQAlAsuTsnvK7xH56d-3BXD7FJvwrwrA8Y-Jj2mokPnYqFHU-CvyfmwuM6HgE6n3o9Fi-kn4lhcbr98Xm0utzdV4e8xlFnnkLiQ5fPVx00xYLp7cCnoMVoMOuIz8sRqF_H5cZ6Tb--uv27fl7efbj5sN7dlx9brVBqxNmANB2a5qREEMADZWjAM2jafYjWrZQ2SS8tYwxEyl6IxRnSyoS07J68PuVPw-xljUkMfl8P0iH6Oag11zaumolm-Ocgu-BgDWjWFftDhQQFVS9lqKVsdys765TF3bgc0_-zfdjO4OAA_T_9JenXce-fH3T6XrFrd_bC9Q8U4o01NBfsDb_eVrA</recordid><startdate>20101201</startdate><enddate>20101201</enddate><creator>Ji, Nana</creator><creator>Yuan, Jianhui</creator><creator>Liu, Jianjun</creator><creator>Tian, Shengli</creator><general>Oxford University Press</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W94</scope><scope>WU4</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20101201</creationdate><title>Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase</title><author>Ji, Nana ; Yuan, Jianhui ; Liu, Jianjun ; Tian, Shengli</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c388t-d78d1fd613f6d4e1713119bf1d31bb211fa34941969f3356e1d1f975dd7c950b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Antineoplastic Agents - pharmacology</topic><topic>ATP Binding Cassette Transporter, Sub-Family G, Member 2</topic><topic>ATP-Binding Cassette Transporters - antagonists &amp; inhibitors</topic><topic>ATP-Binding Cassette Transporters - genetics</topic><topic>ATP-Binding Cassette Transporters - metabolism</topic><topic>Blotting, Western</topic><topic>Breast Neoplasms - metabolism</topic><topic>Breast Neoplasms - pathology</topic><topic>Cell Proliferation - drug effects</topic><topic>DNA Modification Methylases - genetics</topic><topic>DNA Modification Methylases - metabolism</topic><topic>DNA甲基转移酶</topic><topic>Drug Resistance, Neoplasm</topic><topic>Female</topic><topic>Fluorescent Antibody Technique</topic><topic>Gene Expression Regulation, Neoplastic - drug effects</topic><topic>Humans</topic><topic>Mycotoxins - pharmacology</topic><topic>Neoplasm Proteins - genetics</topic><topic>Neoplasm Proteins - metabolism</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Tumor Cells, Cultured</topic><topic>人乳腺癌细胞</topic><topic>多药耐药</topic><topic>实时定量PCR</topic><topic>米托蒽醌</topic><topic>蛋白表达</topic><topic>过度表达</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ji, Nana</creatorcontrib><creatorcontrib>Yuan, Jianhui</creatorcontrib><creatorcontrib>Liu, Jianjun</creatorcontrib><creatorcontrib>Tian, Shengli</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-自然科学</collection><collection>中文科技期刊数据库-自然科学-生物科学</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta biochimica et biophysica Sinica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ji, Nana</au><au>Yuan, Jianhui</au><au>Liu, Jianjun</au><au>Tian, Shengli</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase</atitle><jtitle>Acta biochimica et biophysica Sinica</jtitle><addtitle>Acta Biochimica et Biophysica Sinica</addtitle><date>2010-12-01</date><risdate>2010</risdate><volume>42</volume><issue>12</issue><spage>854</spage><epage>862</epage><pages>854-862</pages><issn>1672-9145</issn><eissn>1745-7270</eissn><abstract>Expression of breast cancer resistance protein/ATP-binding cassette sub-family G member 2 (BCRP/ABCG2) is the major cause of chemotherapy failure. It is important to establish and characterize the multidrug resistance cells and to investigate the mechanism of multidrug resistance. Multidrug-resistant cells expressing BCRP/ABCG2 based on human breast cancer MCF-7/wt cells were developed by gradually increasing application of low concentration of mitoxantrone. Real-time quantitative PCR, western blot, and immunofluorescence assay were employed to analyze BCRP mRNA and protein expression. Drug accumulation in the cells was measured by flow cytometry and DNA methyltransferases were analyzed by western blot. The results indicated that the inhibitory ratio of cell proliferative growth exhibited an exponential relation with the concentration of mitoxantrone. The ICs0 of MCF-7/wt cells to mitoxantrone was found to be 0.42 μM. 3-(4,5-Dimethylthlthiazol-2-YI)- 2,5-Diphenyltetrazolium Bromide assay indicated that the mitoxantrone-resistant cells at different stages exhibited cross-resistance to adriamycin and taxol. BCRP/ABCG2 mRNA and protein levels in the mitoxantrone-resistant cells at different stages increased with increasing concentration of mitoxantrone. Intracellular accumulation of mitoxantrone in the cells decreased with the increase of the BCRP/ABCG2 expression levels. DNA methyltransferase 1 (DNMT1) and DNA methyltransferase 3a (DNMT3a) expressions in the cells at different stages decreased slightly, whereas DNA methyltransferase 3b (DNMT3b) expression decreases significantly. BCRP/ABCG2 overexpression and its drug-efflux function in the drug-resistant cells are the main factors to produce multidrug resistance. Our results suggest that multidrug resistance is related to overexpression of BCRP/ ABCG2 and the decrease of DNA methyltransferases, especially DNMT3b.</abstract><cop>China</cop><pub>Oxford University Press</pub><pmid>21106767</pmid><doi>10.1093/abbs/gmq097</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1672-9145
ispartof Acta biochimica et biophysica Sinica, 2010-12, Vol.42 (12), p.854-862
issn 1672-9145
1745-7270
language eng
recordid cdi_proquest_miscellaneous_814462520
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Antineoplastic Agents - pharmacology
ATP Binding Cassette Transporter, Sub-Family G, Member 2
ATP-Binding Cassette Transporters - antagonists & inhibitors
ATP-Binding Cassette Transporters - genetics
ATP-Binding Cassette Transporters - metabolism
Blotting, Western
Breast Neoplasms - metabolism
Breast Neoplasms - pathology
Cell Proliferation - drug effects
DNA Modification Methylases - genetics
DNA Modification Methylases - metabolism
DNA甲基转移酶
Drug Resistance, Neoplasm
Female
Fluorescent Antibody Technique
Gene Expression Regulation, Neoplastic - drug effects
Humans
Mycotoxins - pharmacology
Neoplasm Proteins - genetics
Neoplasm Proteins - metabolism
Reverse Transcriptase Polymerase Chain Reaction
Tumor Cells, Cultured
人乳腺癌细胞
多药耐药
实时定量PCR
米托蒽醌
蛋白表达
过度表达
title Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T02%3A50%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Developing%20multidrug-resistant%20cells%20and%20exploring%20correlation%20between%20BCRP/ABCG2%20over-expression%20and%20DNA%20methyltransferase&rft.jtitle=Acta%20biochimica%20et%20biophysica%20Sinica&rft.au=Ji,%20Nana&rft.date=2010-12-01&rft.volume=42&rft.issue=12&rft.spage=854&rft.epage=862&rft.pages=854-862&rft.issn=1672-9145&rft.eissn=1745-7270&rft_id=info:doi/10.1093/abbs/gmq097&rft_dat=%3Cproquest_cross%3E814462520%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=814462520&rft_id=info:pmid/21106767&rft_cqvip_id=36305407&rft_oup_id=10.1093/abbs/gmq097&rfr_iscdi=true